Frontlight ResearchEarly access
Childhood cancers trials in United States
933 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleFeasibility Study of Prolonged Administration of Naxitamab, Irinotecan, and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma
- Where
- Boston
- Age
- 1 year to 30 years
- People
- 18
- Run by
- Steven DuBois, MD
See details and how to joinNCT07027748 - No phaseTaking peopleTargeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma
- Where
- Baltimore, Minneapolis, Washington D.C.
- Age
- Up to 39 years
- People
- 70
- Run by
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
See details and how to joinNCT06796543 - No phaseTaking peopleLRG GIST Patient Registry
- Where
- Wayne
- People
- 5,000
- Run by
- The Life Raft Group
See details and how to joinNCT07697248 - No phaseTaking peopleUsing Text Messages to Improve Oral Chemotherapy for Adolescents and Adults With Acute Lymphoblastic Leukemia
- Where
- Chicago
- Age
- 15 years and over
- People
- 48
- Run by
- University of Chicago
See details and how to joinNCT06446661 - Phase 1/2Taking peopleMAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas
- Where
- Chicago, New York, Washington D.C.
- Age
- 1 year to 26 years
- People
- 27
- Run by
- Ann & Robert H Lurie Children's Hospital of Chicago
See details and how to joinNCT06712875 - Phase 1Taking peoplePreliminary Safety and Tolerability of CD19x22 CAR T Cells in Adolescent and Adult R/R B-NHL Patients
- Where
- Aurora
- Age
- 16 years and over
- People
- 68
- Run by
- University of Colorado, Denver
See details and how to joinNCT05098613 - No phaseTaking peopleCD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT
- Where
- Philadelphia
- Age
- Up to 25 years
- People
- 50
- Run by
- Children's Hospital of Philadelphia
See details and how to joinNCT03810196 - Phase 3Taking peopleBrentuximab Vedotin in Early Stage Hodgkin Lymphoma
- Where
- Miami, New York, Stanford
- Age
- 16 years to 69 years
- People
- 1,042 worldwide
- Run by
- University College, London
See details and how to joinNCT04685616 · EU 2022-500031-37-00 - No phaseNot yet taking people in United StatesHealthy Weight Intervention Families During ALL Treatment: NOURISH-ALL
- Where
- Kansas City
- Age
- 2 years to 12 years
- People
- 20
- Run by
- University of Kansas Medical Center
See details and how to joinNCT06050850 - No phaseTaking peopleEvaluation of a Novel Auto Segmentation Algorithm for Normal Structure Delineation in Radiation Treatment Planning
- Where
- Albert Lea, Eau Claire, Jacksonville, La Crosse, Mankato, Rochester, Scottsdale
- People
- 200
- Run by
- Mayo Clinic
See details and how to joinNCT06200116 - No phaseTaking peopleMultilevel Intervention for Precision Oncology
- Where
- New York
- People
- 2,653
- Run by
- VA Office of Research and Development
See details and how to joinNCT06825715 - Phase 1Taking peopleCART123 Cells With or Without Ruxolitinib in Relapsed/Refractory Acute Myeloid Leukemia
- Where
- Philadelphia
- Age
- 0 years to 29 years
- People
- 30
- Run by
- Stephan Grupp MD PhD
See details and how to joinNCT07464951 - No phaseTaking peopleA Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Where
- Akron, Amarillo, Ann Arbor, Atlanta, Augusta, Aurora, Baltimore, Beech Grove, Bethesda, Birmingham, Boston, Brandywine, Buffalo, Chapel Hill, Charleston, Charlotte, Charlottesville, Chicago, Cincinnati, Cleveland, Columbus, Dallas, Denver, Detroit, Duarte, Durham, Fort Sam Houston, Fort Worth, Gainesville, Gilbert, Glendale, Grand Rapids, Hackensack, Hershey, Honolulu, Houston, Indianapolis, Iowa City, Jackson, Jacksonville, Kansas City, La Jolla, Lake Sucess, Little Rock, Loma Linda, Los Angeles, Louisville, Lubbock, Madison, Maywood, Memphis, Miami, Milwaukee, Morgantown, Nashville, New Brunswick, New Haven, New Hyde, New Orleans, New York, Oakland, Oklahoma City, Omaha, Orange, Orlando, Park Ridge, Philadelphia, Phoenix, Pittsburgh, Portland, Providence, Richmond, Rochester, Sacramento, Salt Lake City, San Antonio, San Diego, San Francisco, Seattle, Sioux Falls, Stanford, St Louis, Stony Brook, St. Petersburg, Tampa, The Bronx, Tucson, Washington D.C., Westwood, Winston-Salem, Worcester, Zion
- People
- 99,999
- Run by
- Center for International Blood and Marrow Transplant Research
See details and how to joinNCT01351545 - Phase 1/2Taking peopleET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma
- Where
- Boston, Los Angeles, Orange, San Francisco
- Age
- 1 year to 21 years
- People
- 12
- Run by
- Eureka Therapeutics Inc.
See details and how to joinNCT04634357 - Phase 2Taking peopleAllo HSCT Using RIC and PTCy for Hematological Diseases
- Where
- Minneapolis
- Age
- Up to 75 years
- People
- 56
- Run by
- Masonic Cancer Center, University of Minnesota
See details and how to joinNCT05805605 - No phaseTaking peopleCSIMEMPHIS: Long-term Follow-up of Medulloblastoma Survivors That Received Craniospinal Irradiation
- Where
- Memphis
- People
- 184
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT07085325 - No phaseTaking peopleLocalized Leiomyosarcoma Biomarker Protocol
- Where
- Ann Arbor, Nashville, Rochester
- People
- 40
- Run by
- University of Michigan Rogel Cancer Center
See details and how to joinNCT04925089 - Early phase 1Taking peopleAn Investigational Scan (rhPSMA-7.3 PET/CT) for Detecting Biochemically Recurrent Prostate Cancer, ENLIGHTEN Trial
- Where
- Chicago
- People
- 27
- Run by
- Northwestern University
See details and how to joinNCT06813898 - No phaseTaking peopleMobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia
- Where
- Chicago
- Age
- 14 years and over
- People
- 60
- Run by
- Northwestern University
See details and how to joinNCT03932903 - Phase 1/2Taking peopleAlpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
- Where
- Gainesville
- Age
- 6 months to 25 years
- People
- 27
- Run by
- University of Florida
See details and how to joinNCT06625190 - No phaseTaking peopleOptimizing Health Related Quality of Life Measurement in Adolescent and Young Adult Oncology
- Where
- Winston-Salem
- Age
- 15 years and over
- People
- 3,000
- Run by
- Wake Forest University Health Sciences
See details and how to joinNCT06897137 - No phaseTaking peopleA Feasibility Safety Study of Benign Centrally-Located Intracranial Tumors in Pediatric and Young Adult Subjects
- Where
- Houston, Miami, Washington D.C.
- Age
- 5 years to 22 years
- People
- 20
- Run by
- InSightec
See details and how to joinNCT03028246 - No phaseTaking peopleMolecular Genetics Studies of Cancer Patients and Their Relatives
- Where
- Albuquerque, Amarillo, Bend, Bethesda, Boca Raton, Brighton, Canton, Cedar Rapids, Cheyenne, Chicago, Concord, Duarte, Flemington, Fond du Lac, Fort Lauderdale, Frederick, Fullerton, Houston, Laguna Hills, Laredo, Los Angeles, Lubbock, Mount Kisco, Orange, Paoli, Phoenix, Post Falls, Poughkeepsie, Roseville, Santa Barbara, Waukesha, West Reading
- People
- 999,999 worldwide
- Run by
- City of Hope Medical Center
See details and how to joinNCT04185935 - No phaseTaking peopleCognitive Outcomes After Brain Substructure-informed Radiation Planning in Pediatric Patients
- Where
- Baltimore, Washington D.C.
- Age
- 1 year to 26 years
- People
- 338
- Run by
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
See details and how to joinNCT05658731 - Early phase 1Taking peopleLorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
- Where
- Aurora, Boston, Chicago, Cincinnati, Columbus, Durham, Houston, Philadelphia, Seattle, Washington D.C.
- Age
- 1 year to 21 years
- People
- 15 worldwide
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT06333899